Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand ...

GlaxoSmithKline Pharmaceuticals shares jumped 16% after reporting a five-fold increase in net profit for the third quarter, ...

The company posted a multifold jump per cent in consolidated net profit to Rs 230 crore as compared to Rs 46 crore a year ago ...

GlaxoSmithKline Pharmaceuticals shares surged 20% to ₹2,421.30 after a strong Q3FY25 performance, reporting a 400% rise in ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.80.

GlaxoSmithKline Pharmaceuticals reported a significant increase in net profit to Rs 229 crore for the third quarter ending ...

The Regional Hindi Language Conference, organized by the Ministry of Home Affairs' Language Department, took place at the ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

A wave of deportations from the United States has brought to light disturbing allegations of mistreatment of Indian migrants.

The Centre has extended the PM-AASHA scheme till 2025-26, aiming to ensure remunerative prices for farmers and stabilize ...

Ramkrishna Forgings Ltd saw volume of 30.05 lakh shares by 14:14 IST on NSE, a 5.99 fold spurt over two-week average daily volume of 5.02 lakh shares ...